Investor Overview

Corporate Profile

Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company that is seeking to unlock the full potential of biologic therapies by avoiding unwanted immune responses. Selecta’s tolerogenic Synthetic Vaccine Particles (SVP™) technology platform is designed to enable a range of novel biologics for rare and serious diseases that require new treatment options. The company’s current proprietary pipeline includes SVP-enabled enzyme, oncolo... View more »

Recent News
View all press releases »
Download DocumentationAug 9, 2017
Selecta August 2017 Investor Presentation
Upcoming Events
There are currently no events scheduled.
View all events »
Stock Quote
NASDAQ GS :  SELB (Common Stock)
- 1.1 (6.88%)
Stock chart for: SELB.O.  Currently trading at $14.90 with a 52 week high of $28.00 and a 52 week low of $10.27.
Data as of Aug 18, 2017 2:06 p.m. ET
Minimum 15 minute delay
Refresh quote
IR Contact
Jason Fredette
Selecta Biosciences
Phone: 1 617 231 8078

Data provided by Nasdaq. Minimum 15 minutes delayed.
Back to Top